Human Genome Sciences Inc. v Eli Lilly and Company
Enlazado como:
Extracto
Human Genome Sciences Inc. v Eli Lilly and Company
No longer available (Autolink)
Ver el contenido completo de este documento
Afectaciones
CONSIDERA CASO
- Human Genome Sciences Inc. v Eli Lilly and Company
- Kirin-Amgen v Hoechst Marion Roussel Ltd
- Chiron Corporation v Murex Diagnostics Ltd
[ver más]
REFIERE
- Kirin-Amgen Inc. and Others v Transkaryotic Therapies Inc. and Others and other appeals
- Actavis UK Ltd v Janssen Pharmaceutica NV
- Actavis UK Ltd v Merck & Company Ltd
[ver más]
RESUELVE RECURSO
CONSIDERA
- Patents Act 1977 - Artículos : S-72
- Patents Act 1977 - Artículos : S-1
REPORTED OPINION OF por
CITADA NEUTRALMENTE por
CONSIDERADA por
- Shire Pharmaceutical Contracts Ltd and another (Claimant/Part 20 Defendants) v Mount Sinai School of Medicine of New York University (Defendant/Part 20 Claimant)
- Generics [UK] Ltd trading as Mylan v Yeda Research and Development Company Ltd and Another
- Eli Lilly and Company (Respondent/Claimant) v Human Genome Sciences, Inc. (Appellant/ Defendant)
[ver más]
REFERIDA por